Study on antibiotic resistance of Escherichia coli and Enterococcus colonized in intestine of neonates from neonatal intensive care unit

Chinese Journal of Endemiology

Volumn 38, Issue 9, 2017, Pages 1259-1262

  Xiaofang, Li ^a   Zunjie, Liu ^b   Xia, Chen ^a   Juan, Li ^a   Zhigang, Cui ^a   Biao, Kan ^a   Jianrong, Ma ^b   Jinghua, Cui ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Antibiotic resistance; Enterococcus; Escherichia coli; Neonatal intensive care unit

Indexed keywords

AMIKACIN; AMINE; AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CIPROFLOXACIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERTAPENEM; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; KETONE; MEROPENEM; NITROFURANTOIN; PENICILLIN G; TETRACYCLINE; THIAZOLE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; ENTEROCOCCUS; ESCHERICHIA COLI; FECES ANALYSIS; INTESTINE FLORA; NEONATAL INTENSIVE CARE UNIT; NEWBORN; NONHUMAN;

EID: 85049266701     PISSN: 10004955     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0254-6450.2017.09.023     Document Type: Article

References (10)

1. Wu D, Wang YJ, Jiang M, et al. Antimicrobial resistance analysis of clinical Escherichia coli isolates in hospitalized neonates [J]. Chin J Neonatol, 2016, 3 ((4): 282-285. DOI: 10.3969/j.issn.1673-6710.2016.04.010.
2. Colodner R. Extended-spectrum β-lactamases: a challenge for clinical microbiologists and infection control specialists [J]. Am J Infect Control, 2005, 33 (2): 104-107. DOI: 10.1016/j.ic. 2004.07.010.
3. Mendelson G, Hait V, Ben-Israel J, et al. Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and IKebsieUa pneumoniae in an Israeli long-term care facility [J]. Eur J Clin Microbiol Infect Dis, 2005, 24 (1): 17-22. DOI: 10.1007/s10096-004-1264-8.
4. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory [J]. Clin Microbiol Rev, 1 993, 6(4): 428-442. DOI: 10.1128/CMR.6.4.428.
5. Jiang DX, Chen G, Wang YC, et al. Clinical distribution and drug resistance of exended spectum β-lactamases-producing-Escherichia coli and Klebsiella pneumoniae [J]. Chin J Nosocomiol, 2011, 21(2): 371-373.
6. Sun QY, Pang D, Yi L. Antibiotic resistance of Escherichia coli in neonatal infection in Inner Mongolia Region [J]. Inner Mongolia Med J, 2013, 45 (2): 199-200. DOI: 10.16096/j.cnki.nmgyxzz.2013.02.041.
7. Zhang H, Peng YG, Guo L, et al. Escherichia coli drug sensitivity analysis in hospital infection [J]. Chin J Nosocomiol, 2008, 18 (4): 584-585. DOI: 10.3321/j.issn.1005-4529.2008.04.049.
8. Du Y, Guo C, Hu Y, et al. Integron-mediated multidrug resistance in Escherichia coli clinical strains[J]. Chin J Clin Lab Sci, 2005, 23 (2): 88-90. DOI: 10.3969/j.iisn.1001-764X.2005. 02.003.
9. Qu TT, Yu YS, Sun ZY, et al. CHINET 2011 surveiilance of antibiotic resistance in Enterococcus in China [J]. Chin J Infect Chemother, 2013, 13(5): 337-341. DOI: 10.16718/j.1009-7708.2013.05.003.
10. Lv P, Xu XW, Song WQ, et al. Multidrug resistance of Enterococcal isolates in pediatric and test of class I integron[J]. Lab Med, 2009, 24(3): 219-222. DOI: 10.3969/j.issn.1673-8640. 2009.03.019.